We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Intranasal Morphine for Rapid Breakthrough Pain Relief

By HospiMedica staff writers
Posted on 07 Oct 2002
Morphine gluconate with intranasal delivery couples a sufficient dose with the rapid onset of action necessary to treat opioid-tolerant cancer patients with breakthrough pain.

With intranasal delivery, a drug is absorbed directly into the systemic circulation, bypassing problems that occur with oral administration, including the inactivation of a portion of the administered dose by gastrointestinal and hepatic metabolism. More...
As a result, plasma concentrations of a nasally administered drug often resemble those seen with injectable dosage forms, prompting fast onset of therapeutic effect without the discomfort and inconvenience of an injection. A phase II clinical trial is under way.

The drug was developed by Nastech Pharmaceutical Company, Inc. (Bothell, WA, USA), which has been issued a US patent on a method of making morphine gluconate and a method for eliciting an analgesic or anesthetic response. The company says morphine is the most commonly used opioid to control severe pain because of its wide availability, varied formulations, well-characterized pharmacologic properties, safety, efficacy, and relative ease of titration. However, it is currently not available in a nasal form. Nastech uses a systemic approach to drug development using biophysics, physical chemistry, and pharmacology.

"Over the past 18 months, we have filed dozens of patents to protect our proprietary position in the nasal delivery of both small and large molecule drugs,” noted Steven C. Quay, M.D., Ph.D., chairman, president, and CEO of Nastech.




Related Links:
Nastech

Gold Member
12-Channel ECG
CM1200B
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Tourniquet System
heidi– mein Tourniquet
Vessel Sealing Instrument
ERGOseal
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image

Automated EMR-Based Tool Detects Immune-Related Colitis in Immunotherapy Patients

Immune-related colitis is inflammation of the bowel triggered by cancer immunotherapy with immune checkpoint inhibitors. The condition is common and can be serious, disrupting treatment plans and driving... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.